February 19, 2025
Search
February 19, 2025
Manufactur3D Magazine is India’s Leading and Premier Online Magazine carved out for the 3D Printing Business community in India and globe.
Search
Contents
Subscribe

We will not spam you, receive latest news & product updates.

Stratasys Makes Strategic Investment in Axial3D

Key Takeaways
Investment in Axial3D helps Stratasys to access the broader Personalized 3D printed anatomic model market
Patient-specific 3D-printed anatomic model of a large tumor of the right nasal cavity/Source: Business Wire

Axial3D, a med-tech firm, has announced the completion of a $15 million investment round headed by a $10 million strategic investment from Stratasys Ltd., a leader in polymer 3D printing solutions. This is the company’s first investment in Axial3D. The two firms will also offer a collaborative offering to make patient-specific 3D printing solutions more accessible to hospitals and medical device manufacturers, allowing it to become a mainstream healthcare option.

Personalized 3D printed anatomic models are utilised for pre-surgical planning and diagnostic purposes in order to improve patient outcomes while decreasing operating room time. They are also utilised in education and training, as well as the creation of medical devices. Normally, creating a 3D printed model from a patient’s scan data takes several hours and necessitates a high level of technical competence as well as costly software licences.

Investment in Axial3D

The artificial intelligence-powered algorithms used by Axial3D enable healthcare providers to segment CT and MRI scans for these models without substantial effort, specific skills, or large upfront costs.

Stratasys is a leading manufacturer of 3D printers, materials, and software for anatomic models. The J850™ Digital Anatomy™ 3D printer from the firm allows medical clients to make models that not only properly mimic the appearance of human tissue, but are also biomechanically realistic while suturing, cutting, inserting, and deploying medical devices. With Axial3D software, a variety of Stratasys printers and materials have been validated and FDA 510(k) authorised to manufacture anatomic models for pre-operative surgical planning and diagnostic use across many disciplines.

“We are proud to be partnering with Stratasys, and have always believed in their technology and, more importantly, their vision for 3D printing in healthcare. We believe that to move the industry from early adopters to the mainstream, we need to improve the accessibility of models for healthcare so hospitals and medical device manufacturers can scale their patient-specific programs. Our joint offerings will be the positive, disruptive catalyst that medical 3D printing needs to address 3D printing accessibility.”

– Roger Johnston, CEO, Axial3D

Stratasys estimates the medical 3D printing market to be worth $2.8 billion.

According to Dr. Yoav Zeif, CEO of Stratasys, “Many of the world’s leading hospitals are already benefiting from our MediJet and Digital Anatomy 3D printers for medical models. We believe that by working together with Axial3D, we can remove the barriers to entry for the remaining majority of hospitals in many countries around the world, dramatically growing the use of 3D printing in pre-surgical planning so it is truly a standard part of patient care. This is about providing a complete tailored solution for customers that is fast, automated and scalable.”

Axial3D (booth 8209) and Stratasys (booth 8312) will both display and discuss their joint partnership plans during the Radiological Society of North America’s RSNA 2022 annual meeting and exhibition, which will be held in Chicago from November 27 to December 1.


Manufactur3D Team
Manufactur3D Team reports on the latest news, insights and analysis from the Indian and the Global 3D Printing Industry. They share updates from Industry leading companies to Startups and covers their latest developments.
Share this article
Related Articles

BE A PART OF INDIA'S LARGEST AM PLATFORM

Join a list of 25K+ subscribers who receive weekly AM News, Insights and Analysis